Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
In general, the shorter the needle, the lower the risk of injecting into muscle by accident, especially in people with minimal fat
95% CI -10.78 to -1.10
We partner directly with trusted manufacturers to maintain strict standards of purity and consistency, with high-performance liquid chromatography (HPLC) testing conducted on select batches
In people with obesity and established cardiovascular disease but without diabetes, semaglutide 2.4 mg resulted in 20% reduction in major adverse cardiovascular events [(MACE), death from cardiovascular causes, nonfatal myocardial infarction or nonfatal stroke] compared to placebo (SELECT trial) after a mean follow-up of 39.8 months this is the first trial demonstrating cardiovascular benefit for an obesity pharmacotherapy [110]
US$ 24.00
US$ 29.35
US$ 20.96
US$ 27.74
US$ 29.87
US$ 29.15
US$ 28.97
US$ 21.73
US$ 22.24
US$ 22.37
